Differential involvement of opioid receptors in stress-induced antinociception caused by repeated exposure to forced walking stress in mice.
We examined the effects of repeated exposure to forced walking stress for 6 h once a day for 0, 6 and 9 consecutive days on formalin-induced paw licking in mice. In each observation period, stress-induced antinociception (SIA) was observed only in the late phase (from 10 to 30 min), but not in the early phase (from 0 to 10 min) of formalin-induced paw licking in mice. Moreover, it was hard to develop tolerance even by daily exposure to stress for 6 days, although SIA for 9 days decreased compared with those for 0 and 6 days. Naloxone (10 mg/kg), an opioid-receptor antagonist, was effective in reducing the SIA induced by forced walking stress for 6 days and/or 9 days, but not for 0 days. Furthermore, the experiments with selective opioid-receptor antagonists, beta-funaltrexamine (mu) naltrindol (delta), or nor-binaltorphimine (kappa) demonstrated that SIA induced by forced walking stress for 9 successive days may be mediated through opioid delta- and kappa-receptors. Finally, although SIA seemed to be a unitary phenomenon, the present results strengthened the idea that SIA is induced by exposure to forced walking stress with characteristics dependent on the duration of exposure.
Department of Pharmacology, School of Dentistry, Tohoku University, Sendai, Japan. kenjio@mail.cc.tohoku.ac.jp
K
K
Onodera
S
S
Sakurada
S
S
Furuta
A
A
Yonezawa
K
K
Arai
T
T
Hayashi
S
S
Katsuyama
T
T
Sato
S
S
Miyazaki
K
K
Kisara
D000818:Animals; D005557:Formaldehyde; D008297:Male; D051379:Mice; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010146:Pain / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology; D010147:Pain Measurement / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism*; D013312:Stress, Physiological / Q000503:physiopathology*; D016138:Walking
D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D005557:Formaldehyde; D009270:Naloxone; C051844:norbinaltorphimine; D009271:Naltrexone; C024524:beta-funaltrexamine; C055382:naltrindole